Status:

WITHDRAWN

Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)

Lead Sponsor:

AHEPA University Hospital

Collaborating Sponsors:

Theagenio Cancer Hospital

Conditions:

Cancer

Atrial Fibrillation

Eligibility:

All Genders

18-75 years

Brief Summary

The primary objective is to assess the safety and efficacy of switching from direct oral anticoagulants to low molecular weight heparin in cancer patients during antineoplastic therapy

Detailed Description

This is a single-arm prospective observational study aiming to explore the safety and efficacy of switching from direct oral anticoagulants (DOAC) to low molecular weight heparin (LMWH) in cancer pati...

Eligibility Criteria

Inclusion

  • Subjects diagnosed with cancer other than basal-cell or squamous-cell skin cancer which was objectively confirmed and are programmed for antineoplastic treatment
  • Subjects between 18 to 75 years of age at inclusion
  • Subjects must weigh at least 40 kg at inclusion
  • Subjects receiving direct oral anticoagulant treatment (rivaroxaban, dabigatran, apixaban, edoxaban) for prevention of stroke and systemic embolism in non-valvular atrial fibrillation

Exclusion

  • Patients that have active or serious bleeding within the previous two weeks
  • Patients that have conditions associated with high bleeding risk (active peptic ulcer, recent neurosurgery
  • Patients with platelet count below 50000 per cubic millimeter
  • Patients who have contraindications to heparin (heparin-induced thrombocytopenia)
  • Patients with calculated creatinine clearance \< 30 ml/min using the Cockcroft-Gault formula
  • Women who are pregnant
  • Life expectancy less than 6 months
  • Anticoagulation contraindications
  • Recent brain surgery within 6 months
  • Vascular surgery within 6 months

Key Trial Info

Start Date :

August 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04508855

Start Date

August 1 2020

End Date

December 1 2023

Last Update

July 30 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

AHEPA University Hospital

Thessaloniki, Greece, 54636

2

Theagenio Cancer Hospital

Thessaloniki, Greece